← Back to Search

rDirectCAM for Multiple Sclerosis (TEAMS Trial)

N/A

Waitlist Available

Research Sponsored by University of Alabama at Birmingham

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 48 weeks

Awards & highlights

TEAMS Trial Summary

This trial is comparing the effects of two different models for delivering an exercise, yoga, and Pilates program to adults with multiple sclerosis. The program will be delivered either on-site at a clinic or through telerehabilitation, and participants will be assigned to one of the two groups randomly. The trial has been adapted in response to the Covid-19 pandemic and is now conducting all testing remotely and incorporating a new study group that will receive the program remotely as well.

Eligible Conditions

Multiple Sclerosis

TEAMS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 48 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~48 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 48 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Baseline Fatigue at Month 3 and Month 12

Change in Baseline Pain at Month 3 and Month 12

Change in Baseline Physical Activity at Month 3 and Month 12

+1 more

Secondary outcome measures

Change in Baseline Balance at Month 3 and Month 12

Change in Baseline Endurance at Month 3 and Month 12

Change in Baseline Gait at Month 3 and Month 12

+1 more

Other outcome measures

Exercise self-efficacy

Exercise self-regulation

Outcome expectations for exercise

+1 more

TEAMS Trial Design

3Treatment groups

Experimental Treatment

Group I: rDirectCAMExperimental Treatment1 Intervention

The rDirectCAM arm is being implemented in response to Covid-19. The rDirectCAM arm receives the intervention content delivered remotely in real-time by therapists via videoconferencing technology.

Group II: TeleCAMExperimental Treatment1 Intervention

The TeleCAM arm receives the intervention content at home using pre-loaded tablets and Interactive Voice Response (IVR) system technology.

Group III: DirectCAMExperimental Treatment1 Intervention

The DirectCAM arm receives the intervention content via therapists at participating clinics.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

rDirectCAM

2018

N/A

~920

DirectCAM

2018

N/A

~920

TeleCAM

2018

N/A

~920

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor

1,581 Previous Clinical Trials

2,277,117 Total Patients Enrolled

37 Trials studying Multiple Sclerosis

44,371 Patients Enrolled for Multiple Sclerosis

Patient-Centered Outcomes Research InstituteOTHER

549 Previous Clinical Trials

29,995,864 Total Patients Enrolled

10 Trials studying Multiple Sclerosis

26,380 Patients Enrolled for Multiple Sclerosis

Alabama Neurology Associates, PCOTHER

1 Previous Clinical Trials

30 Total Patients Enrolled

1 Trials studying Multiple Sclerosis

30 Patients Enrolled for Multiple Sclerosis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can I qualify to join this medical trial?

"For admittance to this clinical trial, individuals must have multiple sclerosis and fall within an age range of 18-70. Currently, the study is searching for a total of 912 participants."

Answered by AI

Does this investigation accept volunteers that are over seventy-five years old?

"This clinical trial requires participants to be between the ages of 18 and 70."

Answered by AI

Are there any openings for potential participants to join this experiment?

"According to the details published on clinicaltrials.gov, this trial is not currently recruiting patients although it was originally posted in January 2018 and amended as of September 2022. Nevertheless, 555 other trials from different medical teams are presently enrolling participants."

Answered by AI

How many destinations affords people access to this clinical trial?

"This trial features 40 potential sites, such as Therapy Achievements in Hattiesburg, Gulf Coast Therapy in Huntsville and Encore Rehabilitation in Fulton."

Answered by AI

What key goals are researchers aiming to accomplish through this trial?

"Over a 48 week time frame, this trial aims to determine the effects of physical activity on health. Secondary measurements include strength (measured via hand-held dynamometer), balance (Berg Balance Scale) and gait speed (Timed 25-Foot Walk)."

Answered by AI